# Warfarin

## Cofarin 1mg

##### 

| TAH Drug Code      | [OCOF1](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OCOF1)                                                                                                                                                                                                     |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Treatment & prophylaxis of thromboembolic disorders.                                                                                                                                                                                                                       |
| Dosing             | Initial dose as 2-5mg once daily, depends on patient's PT/INR. Maintenance dose would be 2-10mg, adjusted by patient's PT/INR. Duration of the treatment should be kept until the risks have been excluded.                                                                |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                   |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                              |
| Contraindications  | Severe hepatic or renal disease, actual or potential haemorrhagic conditions, severe hypertension, endocarditis, ulceration of the GI & urinary tract, visceral carcinoma, endocarditis, neurosurgery, recent surgery on the eye, brain or spinal cord. Pregnancy.         |
| Adverse Effects    | Alopecia, skin rashes of various kinds, hemorrhagic skin necrosis. Cardiovascular: Cholesterol embolus syndrome Dermatologic: Tissue necrosis Hematologic: Hemorrhage Immunologic: Hypersensitivity reaction (infrequent ) Ophthalmic: Intraocular hemorrhage (5% to 11% ) |
| Pregnancy          | Contraindicated – 1st Trimester                                                                                                                                                                                                                                            |
| Lactation          | Compatible                                                                                                                                                                                                                                                                 |

## COFARIN 5mg

##### 

| TAH Drug Code      | [OCOF5](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OCOF5)                                                                                                                                                                                                     |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Treatment & prophylaxis of thromboembolic disorders.                                                                                                                                                                                                                       |
| Dosing             | Initial dose as 2-5mg once daily, depends on patient's PT/INR. Maintenance dose would be 2-10mg, adjusted by patient's PT/INR. Duration of the treatment should be kept until the risks have been excluded.                                                                |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                   |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                              |
| Contraindications  | Severe hepatic or renal disease, actual or potential haemorrhagic conditions, severe hypertension, endocarditis, ulceration of the GI & urinary tract, visceral carcinoma, endocarditis, neurosurgery, recent surgery on the eye, brain or spinal cord. Pregnancy.         |
| Adverse Effects    | Alopecia, skin rashes of various kinds, hemorrhagic skin necrosis. Cardiovascular: Cholesterol embolus syndrome Dermatologic: Tissue necrosis Hematologic: Hemorrhage Immunologic: Hypersensitivity reaction (infrequent ) Ophthalmic: Intraocular hemorrhage (5% to 11% ) |
| Pregnancy          | Contraindicated – 1st Trimester                                                                                                                                                                                                                                            |
| Lactation          | Compatible                                                                                                                                                                                                                                                                 |

